Xbiotech announces first patient enrolled in clinical trial evaluating xb2001 for the treatment of pancreatic cancer

Xb2001 is a novel therapy that interrupts inflammation to potentially block growth and spread of tumors and to reduce toxicity of chemotherapy treatment xb2001 is a novel therapy that interrupts inflammation to potentially block growth and spread of tumors and to reduce toxicity of chemotherapy treatment
XBIT Ratings Summary
XBIT Quant Ranking